Jupiter Neurosciences (JUNS) Stock: Buy, Sell, or Hold?
JUNS - Jupiter Neurosciences, Inc. Common Stock
$3.05
-0.10 (-3.17%)
▼
5d:
-6.44%
30d:
-33.84%
90d:
+1231.88%
HOLD
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When JUNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JUNS trades at premium valuation expecting 43.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: JUNS trades at premium valuation expecting 43.1% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: JUNS is currently trading at $3.05, which is considered slightly low relative to its 30-day fair value range of $2.64 to $5.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 50.8) compared to its historical average (17.4). At these levels, the market is pricing in 43.1% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, JUNS is in a strong uptrend. Immediate support is located at $2.88, while resistance sits at $5.15. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: JUNS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+883.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JUNS is in a strong uptrend. Immediate support is located at $2.88, while resistance sits at $5.15. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: JUNS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+883.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.64 -
$5.63
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 883.6% below Wall St target ($30.00)
- BEARISH: Market expects 43.1% growth - appears too optimistic based on history
- CAUTION: Bottoming setup, but lagging the sector by 46% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.64 -
$5.63
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.88
Resistance Level
$5.15
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.83
Wall Street Target
$30.00
(+883.6%)
Valuation Premium vs History
+43.1% premium
PE vs Historical
50.8 vs 17.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+43.1%
(market-implied from PE analysis)
1-Year Target
$4.36
(+43%)
2-Year Target
$6.25
(+105%)
3-Year Target
$8.94
(+193%)
3-Yr Target (if PE normalizes)
(PE: 51→17)
PE COMPRESSION
$3.06
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 13, 2026 11:58 AM ET
Data refreshes hourly during market hours. Next update: 12:58 PM
Data refreshes hourly during market hours. Next update: 12:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JUNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
LRMR
Larimar Therapeutics Inc |
STRONG BUY
11 analysts |
$14 | 58 HOLD |
